Marker Therapeutics (MRKR) Other Non-Current Liabilities (2011 - 2015)

Marker Therapeutics (MRKR) has 5 years of Other Non-Current Liabilities data on file, last reported at $26.5 million in Q4 2015.

• Other Non-Current Liabilities for Q4 2015 came in at $26.5 million, up 294266.67% year-over-year; the trailing twelve-month figure through Dec 2015 was $26.5 million (up 294266.67% YoY), and the FY2015 annual result was $26.5 million, up 294266.67% from the prior year.
• Other Non-Current Liabilities retreated to $26.5 million in Q4 2015 per MRKR's latest filing, from $32.2 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $70.0 million in Q2 2015 and troughed at $9000.0 in Q4 2014.
• A 5-year average of $15.7 million and a median of $1.3 million in 2011 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2012 and 2015: Other Non-Current Liabilities sank 48.62% in 2012, then soared 294266.67% in 2015.
• A 5-year view of Other Non-Current Liabilities shows it stood at $1.3 million in 2011, then slumped by 48.62% to $677086.0 in 2012, then tumbled by 31.72% to $462293.0 in 2013, then plunged by 98.05% to $9000.0 in 2014, then soared by 294266.67% to $26.5 million in 2015.
• Business Quant data shows MRKR's Other Non-Current Liabilities at $26.5 million in Q4 2015, $32.2 million in Q3 2015, and $70.0 million in Q2 2015.